Literature DB >> 23820265

Oncogenic functions of the transcription factor Nrf2.

Irene Gañán-Gómez1, Yue Wei2, Hui Yang2, María Carmen Boyano-Adánez3, Guillermo García-Manero2.   

Abstract

Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that controls the expression of a large pool of antioxidant and cytoprotective genes regulating the cellular response to oxidative and electrophilic stress. Nrf2 is negatively regulated by Kelch-like ECH-associated protein 1 (Keap1) and, upon stimulation by an oxidative or electrophilic insult, is rapidly activated by protein stabilization. Owing to its cytoprotective functions, Nrf2 has been traditionally studied in the field of chemoprevention; however, there is accumulated evidence that Keap1/Nrf2 mutations or unbalanced regulation that leads to overexpression or hyperactivation of Nrf2 may participate in tumorigenesis and be involved in chemoresistance of a wide number of solid cancers and leukemias. In addition to protecting cells from reactive oxygen species, Nrf2 seems to play a direct role in cell growth control and is related to apoptosis-regulating pathways. Moreover, Nrf2 activity is connected with oncogenic kinase pathways, structural proteins, hormonal regulation, other transcription factors, and epigenetic enzymes involved in the pathogenesis of various types of tumors. The aim of this review is to compile and summarize existing knowledge of the oncogenic functions of Nrf2 to provide a solid basis for its potential use as a molecular marker and pharmacological target in cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AML; ARE; Apoptosis; Autophagy; C/EBP homologous protein; CHOP; CML; COL; Cancer; Cell growth; Chemoresistance; Cytoprotection; EOC; ER; ERK; ESCC; Electrophiles; Free radicals; GSK-3β; HCC; JNK; Keap1; LC3α; LOH; MAP kinase-ERK kinase; MDR; MEK; MGMT; Mutation; NSCLC; Nrf2; Oxidative stress; PI3K; PKC; PT; Proto-oncogene; SAHA; SCC; STC; Tumorigenesis; acute myeloid leukemia; antioxidant response element; b-ZIP; c-Jun N-terminal kinase; chronic myelogenous leukemia; colorectal carcinoma; epithelial ovarian carcinoma; esophagus squamous cell carcinoma; estrogen receptor; extracellular-regulated MAP kinase; glycogen synthase kinase 3β; hepatocellular carcinoma; kinase light chain 3α; leucine-zipper protein; loss of heterogeneity; mTOR; mammalian target of rapamycin; methylguanine DNA-methyltransferase; multidrug resistance; non-small-cell lung carcinoma; phosphatidylinositol-4, 5-bisphosphate 3-kinase; primary tumor; protein kinase C; squamous cell carcinoma; stomach carcinoma; suberoylanilide hydroxamic acid

Mesh:

Substances:

Year:  2013        PMID: 23820265     DOI: 10.1016/j.freeradbiomed.2013.06.041

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  89 in total

1.  Nrf2 promotes progression of non-small cell lung cancer through activating autophagy.

Authors:  Jing Wang; Zhiyan Liu; Tinghua Hu; Lili Han; Shuo Yu; Yu Yao; Zhiping Ruan; Tao Tian; Tianhe Huang; Mincong Wang; Li Jing; Kejun Nan; Xuan Liang
Journal:  Cell Cycle       Date:  2017-04-12       Impact factor: 4.534

2.  Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation.

Authors:  Carolina Arenas Valencia; Liliana Lopez Kleine; Andres M Pinzon Velasco; Andrea Y Cardona Barreto; Clara E Arteaga Diaz
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 3.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies.

Authors:  Mans Broekgaarden; Ruud Weijer; Thomas M van Gulik; Michael R Hamblin; Michal Heger
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

Review 4.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

5.  Mitochondrial permeabilization without caspase activation mediates the increase of basal apoptosis in cells lacking Nrf2.

Authors:  Julia Ariza; José A González-Reyes; Laura Jódar; Alberto Díaz-Ruiz; Rafael de Cabo; José Manuel Villalba
Journal:  Free Radic Biol Med       Date:  2016-03-22       Impact factor: 7.376

6.  Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.

Authors:  K Diehl; L-A Dinges; O Helm; N Ammar; D Plundrich; A Arlt; C Röcken; S Sebens; H Schäfer
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

7.  Nrf2-peroxiredoxin I axis in polymorphous adenocarcinoma is associated with low matrix metalloproteinase 2 level.

Authors:  J M Brod; Ana Paula Dias Demasi; V A Montalli; L N Teixeira; C Furuse; M C Aguiar; A B Soares; M Sperandio; V C Araujo
Journal:  Virchows Arch       Date:  2017-08-28       Impact factor: 4.064

8.  Role of reactive oxygen species in arsenic-induced transformation of human lung bronchial epithelial (BEAS-2B) cells.

Authors:  Zhuo Zhang; Poyil Pratheeshkumar; Amit Budhraja; Young-Ok Son; Donghern Kim; Xianglin Shi
Journal:  Biochem Biophys Res Commun       Date:  2014-12-10       Impact factor: 3.575

Review 9.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

10.  The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.

Authors:  Zhiwei Chen; Xiangyun Ye; Naiwang Tang; Shengping Shen; Ziming Li; Xiaomin Niu; Shun Lu; Ling Xu
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.